These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 38542249)

  • 1. Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together.
    Maresca R; Mignini I; Varca S; Calvez V; Termite F; Esposto G; Laterza L; Scaldaferri F; Ainora ME; Gasbarrini A; Zocco MA
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study.
    Abenavoli L; Spagnuolo R; Scarlata GGM; Scarpellini E; Boccuto L; Luzza F
    Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38003983
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-alcoholic fatty liver degree and long-term risk of incident inflammatory bowel disease: A large-scale prospective cohort study.
    Zhang Q; Liu S; Wu J; Zhu S; Wu Y; Wu S; Zhang S
    Chin Med J (Engl); 2024 Jul; 137(14):1705-1714. PubMed ID: 37962217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review and Meta-Analysis: Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Inflammatory Bowel Disease.
    Navarro P; Gutiérrez-Ramírez L; Tejera-Muñoz A; Arias Á; Lucendo AJ
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis: prevalence of, and risk factors for, non-alcoholic fatty liver disease in patients with inflammatory bowel disease.
    Zamani M; Alizadeh-Tabari S; Singh S; Loomba R
    Aliment Pharmacol Ther; 2022 Apr; 55(8):894-907. PubMed ID: 35274325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history.
    Magrì S; Paduano D; Chicco F; Cingolani A; Farris C; Delogu G; Tumbarello F; Lai M; Melis A; Casula L; Fantini MC; Usai P
    World J Gastroenterol; 2019 Oct; 25(37):5676-5686. PubMed ID: 31602167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease.
    Sourianarayanane A; Garg G; Smith TH; Butt MI; McCullough AJ; Shen B
    J Crohns Colitis; 2013 Sep; 7(8):e279-85. PubMed ID: 23158500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of NAFLD on Hospitalization Outcomes in Patients With Inflammatory Bowel Diseases: Nationwide Analysis.
    Noorian S; Jeon Y; Nguyen MT; Sauk J; Limketkai BN
    Inflamm Bowel Dis; 2022 Jun; 28(6):878-887. PubMed ID: 34374782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Other Side of Malnutrition in Inflammatory Bowel Disease (IBD): Non-Alcoholic Fatty Liver Disease.
    Gibiino G; Sartini A; Gitto S; Binda C; Sbrancia M; Coluccio C; Sambri V; Fabbri C
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review article.
    Chao CY; Battat R; Al Khoury A; Restellini S; Sebastiani G; Bessissow T
    World J Gastroenterol; 2016 Sep; 22(34):7727-34. PubMed ID: 27678354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral manifestations of inflammatory bowel disease: the neglected piece of the puzzle.
    Sbeit W; Kadah A; Mahamid M; Karayanni H; Mari A; Tali S; Srouji S; Khoury T
    Eur J Gastroenterol Hepatol; 2020 Nov; 32(11):1422-1431. PubMed ID: 32925508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay.
    Abenavoli L; Giubilei L; Procopio AC; Spagnuolo R; Luzza F; Boccuto L; Scarpellini E
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview.
    Pagani K; Lukac D; Bhukhan A; McGee JS
    Am J Clin Dermatol; 2022 Jul; 23(4):481-497. PubMed ID: 35441942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.
    Carr RM; Patel A; Bownik H; Oranu A; Kerner C; Praestgaard A; Forde KA; Reddy KR; Lichtenstein GR
    Dig Dis Sci; 2017 May; 62(5):1354-1361. PubMed ID: 28265826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease.
    Hyun HK; Lee HW; Park J; Park SJ; Park JJ; Kim TI; Lee JS; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU; Cheon JH
    Gut Liver; 2024 Mar; 18(2):294-304. PubMed ID: 37203442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Extraintestinal manifestations in inflammatory bowel disease].
    Vavricka SR
    Ther Umsch; 2023 Dec; 80(9):393-397. PubMed ID: 38095252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Features Focusing on Extraintestinal Manifestations in Japanese Patients with Inflammatory Bowel Diseases: Far East 1000.
    Ohta Y; Taida T; Kato J; Ogasawara S; Oyama Y; Mamiya Y; Nakazawa H; Horio R; Goto C; Takahashi S; Kurosugi A; Sonoda M; Shiratori W; Kaneko T; Yokoyama Y; Akizue N; Ishigami H; Koseki H; Okimoto K; Saito K; Saito M; Matsumura T; Nakagawa T; Masuya Y; Fukuda Y; Kitsukawa Y; Shimura H; Tsuyuguchi T; Kato N
    Digestion; 2023; 104(4):328-334. PubMed ID: 36893744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study.
    Busingye D; Pollack A; Chidwick K
    PLoS One; 2021; 16(5):e0252458. PubMed ID: 34043730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: a systematic review.
    Spagnuolo R; Abenavoli L; Corea A; Larussa T; Mancina RM; Cosco C; Luzza F; Doldo P
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5818-5825. PubMed ID: 34604973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crohn's Disease Is Associated with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
    Aggarwal M; Garg R; Parthasarthy G; Nowacki AS; Padival R; McCullough A; Qazi T; Click B; Rieder F; Cohen BL
    Dig Dis Sci; 2023 Mar; 68(3):1006-1015. PubMed ID: 35731428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.